Blood group ABO polymorphism inhibits SARS-CoV-2 infection and affects COVID-19 progression
- PMID: 32965025
- PMCID: PMC7537232
- DOI: 10.1111/vox.13004
Blood group ABO polymorphism inhibits SARS-CoV-2 infection and affects COVID-19 progression
Figures
Comment on
-
Association between ABO blood groups and risk of SARS-CoV-2 pneumonia.Br J Haematol. 2020 Jul;190(1):24-27. doi: 10.1111/bjh.16797. Epub 2020 May 26. Br J Haematol. 2020. PMID: 32379894 Free PMC article. No abstract available.
-
Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility.Clin Infect Dis. 2021 Jul 15;73(2):328-331. doi: 10.1093/cid/ciaa1150. Clin Infect Dis. 2021. PMID: 32750119 Free PMC article.
References
-
- Centers for Disease Control and Prevention (CDC) : Coronavirus Disease 2019 (COVID‐19), People at Increased Risk for Severe Illness. Available online: https://www.cdc.gov/coronavirus/2019‐ncov/need‐extra‐precautions/index.html (accessed on 20 August 2020).
-
- Arendrup M, Hansen JE, Clausen H, et al.: Antibody to histo‐blood group A antigen neutralizes HIV produced by lymphocytes from blood group A donors but not from blood group B or O donors. AIDS 1991; 5:441–444 - PubMed
-
- Preece AF, Strahan KM, Devitt J, et al.: Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement. Blood 2002; 99:2477–2482 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous